Xin-Xin I. Zeng
- Pharmacology top 10%
-
- Congenital heart defects research 4
- Developmental Biology and Gene Regulation 2
-
- Congenital Heart Disease Studies 3
-
- Lung Cancer Research Studies 2
- Neutropenia and Cancer Infections 2
-
- Lung Cancer Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
-
- Congenital limb and hand anomalies 1
- Co-authors
- Lilianna Solnica‐KrezelDiane S. SepichThomas P. WilmDeborah YelonSara R. MarquesC. NeilFrank L. ConlonThomas E. Callis
- Partner nations
- United StatesChina
In The Last Decade
Xin-Xin I. Zeng
15 papers receiving 375 citations
Peers
Comparison fields: 5 of 53
- Pharmacology 95
- Cellular and Molecular Neuroscience 77
- Molecular Biology 232
- Cell Biology 51
- Surgery 137
Countries citing papers authored by Xin-Xin I. Zeng
This map shows the geographic impact of Xin-Xin I. Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin-Xin I. Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin-Xin I. Zeng more than expected).
Fields of papers citing papers by Xin-Xin I. Zeng
This network shows the impact of papers produced by Xin-Xin I. Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin-Xin I. Zeng. The network helps show where Xin-Xin I. Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin-Xin I. Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 6 | |
| 11 | 2020 | 4 | |
| 12 | 2019 | 56 | |
| 13 | 2017 | 26 | |
| 14 | 2017 | 28 | |
| 15 | 2014 | 29 | |
| 16 | 2010 | 45 | |
| 17 | 2009 | 25 | |
| 18 | 2007 | 142 |
About Xin-Xin I. Zeng
Xin-Xin I. Zeng is a scholar working on Developmental Biology, Hepatology, Oncology, Biochemistry and Microbiology, having authored 18 papers that have together received 378 indexed citations. Recurring topics across this work include Congenital heart defects research (4 papers), Congenital Heart Disease Studies (3 papers), Lung Cancer Research Studies (2 papers), Neutropenia and Cancer Infections (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers), Developmental Biology and Gene Regulation (2 papers) and Congenital limb and hand anomalies (1 paper). The work is most often cited by research in Pharmacology (95 citations), Cellular and Molecular Neuroscience (77 citations), Molecular Biology (232 citations), Cell Biology (51 citations) and Surgery (137 citations). Xin-Xin I. Zeng has collaborated with scholars based in United States and China. Frequent co-authors include Lilianna Solnica‐Krezel, Diane S. Sepich, Thomas P. Wilm, Deborah Yelon, Sara R. Marques, C. Neil, Frank L. Conlon, Thomas E. Callis, Elizabeth M. Mandel and Da‐Zhi Wang. Their work appears in journals such as Journal of Clinical Oncology, Development, Developmental Cell, Frontiers in Cell and Developmental Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.